CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 127 filers reported holding CARIBOU BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $17,404 | -80.1% | 10,612 | -37.7% | 0.00% | -81.8% |
| Q1 2024 | $87,503 | +49.3% | 17,024 | +66.5% | 0.01% | 0.0% |
| Q4 2023 | $58,595 | +442.9% | 10,226 | +352.9% | 0.01% | +266.7% |
| Q3 2023 | $10,793 | +215.5% | 2,258 | +180.5% | 0.00% | +200.0% |
| Q2 2023 | $3,421 | -22.1% | 805 | -2.7% | 0.00% | 0.0% |
| Q1 2023 | $4,391 | +12.8% | 827 | +33.4% | 0.00% | -50.0% |
| Q4 2022 | $3,894 | -35.1% | 620 | +8.8% | 0.00% | -33.3% |
| Q3 2022 | $6,000 | – | 570 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 544,196 | $5,741,000 | 19.52% |
| Elmwood Wealth Management, Inc. | 2,364,240 | $24,943,000 | 12.45% |
| 72 Investment Holdings, LLC | 474,067 | $5,001,000 | 3.96% |
| PFM Health Sciences, LP | 6,000,000 | $63,300,000 | 2.29% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 257,892 | $2,716,000 | 0.87% |
| Avidity Partners Management LP | 3,172,600 | $33,471,000 | 0.68% |
| Green Alpha Advisors, LLC | 69,376 | $732,000 | 0.62% |
| Rokos Capital Management LLP | 1,907,509 | $20,811,000 | 0.62% |
| Nelson Capital Management, LLC | 85,020 | $897,000 | 0.26% |
| Tekla Capital Management LLC | 567,147 | $5,983,000 | 0.24% |